Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
ISRN Cardiology|October 26, 2012
Clinical evaluation of a mobile heart rhythm telemonitoring systemHristo Mateev, Iana Simova, Tzvetana Katova, et al.
Echocardiography (Mount Kisco, N.Y.)|June 9, 2015
Comparison between Regional and Local Pulse-Wave Velocity DataIana Simova, Tzvetana Katova, Ciro Santoro, et al.
Echocardiography (Mount Kisco, N.Y.)|March 15, 2011
Reproducibility of arterial stiffness indices in different vascular territories and between different observersIana Simova, Tzvetana Katova, Velislava Kostova, et al.
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.
JACC. Heart Failure|March 14, 2021
Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF TrialKarola Jering, Brian Claggett, Margaret M Redfield, et al.
JAMA Cardiology|March 31, 2021
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure TrialJawad H Butt, Kieran F Docherty, Mark C Petrie, et al.
JACC. Heart Failure|February 7, 2021
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HFLi Shen, Søren Lund Kristensen, Olof Bengtsson, et al.
JAMA Cardiology|November 17, 2024
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMisato Chimura, Xiaowen Wang, Pardeep S Jhund, et al.
European Journal of Heart Failure|June 26, 2024
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fractionMingming Yang, Toru Kondo, Pardeep S Jhund, et al.
European Heart Journal|March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapyKieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
Pageof 3